Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers
Open Access
- 1 August 2015
- journal article
- research article
- Published by Elsevier BV in Journal of Thoracic Oncology
- Vol. 10 (8), 1213-1220
- https://doi.org/10.1097/jto.0000000000000585
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Increased Red Blood Cell Distribution Width Associates with Cancer Stage and Prognosis in Patients with Lung CancerPLOS ONE, 2013
- Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapyBMC Cancer, 2013
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03European Journal of Cancer, 2009
- Prognostic factors differ by tumor stage for small cell lung cancerCancer, 2009
- Neutrophil/lymphocyte ratio and its association with survival after complete resection in non–small cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Cancer-related inflammationNature, 2008
- Limited-Stage Small-Cell Lung Cancer: The Current Status of Combined-Modality TherapyJournal of Clinical Oncology, 2007
- Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results DatabaseJournal of Clinical Oncology, 2006
- Thrombocytosis as a Useful Prognostic Indicator in Patients with Lung CancerRespiration, 2004